T Delate

Summary

Affiliation: Express Scripts
Country: USA

Publications

  1. ncbi Commentary on using the SF-36 or MOS-HIV in studies of persons with HIV disease
    Jim Shahriar
    Quality Programs, Health Care Services, Blue Shield of California, San Francisco, CA 94105, USA
    Health Qual Life Outcomes 1:25. 2003
  2. ncbi Patterns of use of sildenafil among commercially insured adults in the United States: 1998-2002
    T Delate
    Express Scripts, Inc, 13900 Riverport Dr STL12N, Maryland Heights, Missouri 63043, USA
    Int J Impot Res 16:313-8. 2004
  3. ncbi Trends in the use of antidepressants in a national sample of commercially insured pediatric patients, 1998 to 2002
    Thomas Delate
    Express Scripts, Inc, Maryland Heights, Missouri 63043, USA
    Psychiatr Serv 55:387-91. 2004
  4. ncbi Clinical and financial outcomes associated with a proton pump inhibitor prior-authorization program in a Medicaid population
    Thomas Delate
    Outcomes Research, Express Scripts, Inc, Maryland Heights, MO, USA
    Am J Manag Care 11:29-36. 2005
  5. ncbi Medication strategies used by Medicare beneficiaries who reach the Part D standard drug-benefit threshold
    Amber Cronk
    Department of Pharmacy, Kaiser Permanente Colorado, Aurora, CO 80011 9045, USA
    Am J Health Syst Pharm 65:1062-70. 2008
  6. ncbi Actual versus projected cost avoidance for clinical pharmacy specialist-initiated medication conversions in a primary care setting in an integrated health system
    Beverly A Kroner
    Chief of Primary Care Clinical Pharmacy Services, Kaiser Permanente, Colorado Region, Aurora, CO 80011, USA
    J Manag Care Pharm 14:155-63. 2008
  7. ncbi Outcomes associated with combined antiplatelet and anticoagulant therapy
    Samuel G Johnson
    Kaiser Permanente Colorado Region, Clinical Pharmacy Services, Aurora, CO 80011, USA
    Chest 133:948-54. 2008
  8. ncbi Mortality reduction benefits of a comprehensive cardiac care program for patients with occlusive coronary artery disease
    John A Merenich
    Department of Endocrinology, Colorado Permanente Medical Group, Denver, Colorado, USA
    Pharmacotherapy 27:1370-8. 2007
  9. ncbi Coronary artery disease and hypertension: outcomes of a pharmacist-managed blood pressure program
    Karen J McConnell
    Clinical Pharmacy Cardiac Risk Service, Kaiser Permanente of Colorado, Aurora, Colorado 80011, USA
    Pharmacotherapy 26:1333-41. 2006
  10. ncbi Effects of reaching the drug benefit threshold on Medicare members' healthcare utilization during the first year of Medicare Part D
    Marsha A Raebel
    Kaiser Permanente Colorado Institute for Health Research, Denver, Colorado 80237, USA
    Med Care 46:1116-22. 2008

Collaborators

Detail Information

Publications10

  1. ncbi Commentary on using the SF-36 or MOS-HIV in studies of persons with HIV disease
    Jim Shahriar
    Quality Programs, Health Care Services, Blue Shield of California, San Francisco, CA 94105, USA
    Health Qual Life Outcomes 1:25. 2003
    ..Using both a generic and targeted HRQOL measure is a good general strategy, but this has not been a typical practice in studies of HIV because the MOS-HIV is so similar in content to the SF-36...
  2. ncbi Patterns of use of sildenafil among commercially insured adults in the United States: 1998-2002
    T Delate
    Express Scripts, Inc, 13900 Riverport Dr STL12N, Maryland Heights, Missouri 63043, USA
    Int J Impot Res 16:313-8. 2004
    ..Our findings suggest that use may increase among younger male and female patients and those without an underlying etiologic reason for use...
  3. ncbi Trends in the use of antidepressants in a national sample of commercially insured pediatric patients, 1998 to 2002
    Thomas Delate
    Express Scripts, Inc, Maryland Heights, Missouri 63043, USA
    Psychiatr Serv 55:387-91. 2004
    ..The aim of this study was to estimate the prevalence of use of prescription antidepressants among children and adolescents by using nationwide data and to examine trends in use from 1998 to 2002...
  4. ncbi Clinical and financial outcomes associated with a proton pump inhibitor prior-authorization program in a Medicaid population
    Thomas Delate
    Outcomes Research, Express Scripts, Inc, Maryland Heights, MO, USA
    Am J Manag Care 11:29-36. 2005
    ..To examine the clinical and financial outcomes associated with a proton pump inhibitor (PPI) prior-authorization policy...
  5. ncbi Medication strategies used by Medicare beneficiaries who reach the Part D standard drug-benefit threshold
    Amber Cronk
    Department of Pharmacy, Kaiser Permanente Colorado, Aurora, CO 80011 9045, USA
    Am J Health Syst Pharm 65:1062-70. 2008
    ..The mechanisms used by Medicare beneficiaries who reached their Part D drug-benefit threshold to cope with the costs of prescription drugs were evaluated...
  6. ncbi Actual versus projected cost avoidance for clinical pharmacy specialist-initiated medication conversions in a primary care setting in an integrated health system
    Beverly A Kroner
    Chief of Primary Care Clinical Pharmacy Services, Kaiser Permanente, Colorado Region, Aurora, CO 80011, USA
    J Manag Care Pharm 14:155-63. 2008
    ..Validation of cost-avoidance projections is also difficult because traditional projection methods have several limitations...
  7. ncbi Outcomes associated with combined antiplatelet and anticoagulant therapy
    Samuel G Johnson
    Kaiser Permanente Colorado Region, Clinical Pharmacy Services, Aurora, CO 80011, USA
    Chest 133:948-54. 2008
    ..The objective of this study was to estimate and compare the incidence of adverse and coronary event rates between patients receiving warfarin monotherapy or warfarin and antiplatelet combination therapy...
  8. ncbi Mortality reduction benefits of a comprehensive cardiac care program for patients with occlusive coronary artery disease
    John A Merenich
    Department of Endocrinology, Colorado Permanente Medical Group, Denver, Colorado, USA
    Pharmacotherapy 27:1370-8. 2007
    ..To determine the effect of early and sustained enrollment in a comprehensive cardiac care (CCC) program on all-cause mortality in patients with coronary artery disease (CAD)...
  9. ncbi Coronary artery disease and hypertension: outcomes of a pharmacist-managed blood pressure program
    Karen J McConnell
    Clinical Pharmacy Cardiac Risk Service, Kaiser Permanente of Colorado, Aurora, Colorado 80011, USA
    Pharmacotherapy 26:1333-41. 2006
    ..To assess the effectiveness of a pharmacist-managed service in improving hypertension control among patients with coronary artery disease...
  10. ncbi Effects of reaching the drug benefit threshold on Medicare members' healthcare utilization during the first year of Medicare Part D
    Marsha A Raebel
    Kaiser Permanente Colorado Institute for Health Research, Denver, Colorado 80237, USA
    Med Care 46:1116-22. 2008
    ..Information on the effects of reaching the Medicare Part D standard drug benefit threshold is limited...